Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analyses of multi-omics differences between patients with high and low PD1/PDL1 expression in lung squamous cell carcinoma.

International immunopharmacology - 1 Nov 2020

Hu Zhengyang, Bi Guoshu, Sui Qihai, Bian Yunyi, Du Yajing, Liang Jiaqi, Li Ming, Zhan Cheng, Lin Zongwu, Wang Qun

Abstract excerpt

BACKGROUND: Immunotherapy has achieved excellent results in patients with lung squamous cell carcinoma. However, in which population it can exert the greatest effect is still unknown. Some studies have suggested that its effect is related to the expression level of PD1. Analyzing the relationship between PD1 expression level and genetic differences in lung squamous cell carcinoma patients will be helpful in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Gene Expression Regulation, Neoplastic

Share to Genomics

Share to MicroRNAs

Share to Programmed Cell Death 1 Receptor

Share to RNA-Seq

Source

Identifiers

PMID: 32829091
DOI: 10.1016/j.intimp.2020.106910

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analyses of multi-omics differences between patients with high and low PD1/PDL1 expression in lung squamous cell carcinoma.PMID 32829091Read ↗

Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.Semantic proximity Read ↗

Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinomaSemantic proximity Read ↗

In-Depth Genomic Characterization of Programmed Cell Death Ligand 1 (PD-L1) Expression in Chinese Lung Adenocarcinoma PatientsSemantic proximity Read ↗

Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma.Semantic proximity Read ↗

Multidimensional characterization of the tumor microenvironment profiles in lung squamous cell carcinoma.Semantic proximity Read ↗

Whole Exome and Transcriptome Analyses Integrated with Microenvironmental Immune Signatures of Lung Squamous Cell Carcinoma.Semantic proximity Read ↗

Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patientsSemantic proximity Read ↗

Association Between Tumor Mutation Burden (TMB) and immune microenvironment in lung squamous cell carcinomaSemantic proximity Read ↗

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung AdenocarcinomaSemantic proximity Read ↗

SIRPG promotes lung squamous cell carcinoma pathogenesis via M1 macrophages: a multi-omics study integrating data and Mendelian randomizationSemantic proximity Read ↗

The tumor environment immune phenotype of LUSC by genome-wide analysis.Semantic proximity Read ↗

TP53 and LRP1B Co-Wild Predicts Improved Survival for Patients with LUSC Receiving Anti-PD-L1 ImmunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.